SCIENTIFEQ LTD

Company Registration Number:
15258984 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2024

Period of accounts

Start date: 3 November 2023

End date: 31 December 2024

SCIENTIFEQ LTD

Contents of the Financial Statements

for the Period Ended 31 December 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

SCIENTIFEQ LTD

Directors' report period ended 31 December 2024

The directors present their report with the financial statements of the company for the period ended 31 December 2024

Principal activities of the company

The principal activity of the company during the year continued to be that of a diagnostic laboratory specialising in parasite testing and analysis for animal health. ScientifEQ Ltd provides professional testing services for veterinarians, equine establishments, breeders, and animal health professionals across the United Kingdom.

Political and charitable donations

The company made no political donations or contributions during the financial year.

Company policy on disabled employees

Policy on Discrimination and Disabled Employees Approved by: Diane Elizabeth Gilby Date of approval: 30 September 2025 Next review date: 30 September 2026 Purpose and Scope ScientifEQ Ltd is committed to promoting equality of opportunity and creating an inclusive working environment in which all individuals are treated with dignity and respect. This policy applies to all employees, contractors, job applicants, and anyone working on behalf of the company. It covers all stages of employment; recruitment, training, promotion, working conditions, and termination. The purpose of this policy is to prevent unlawful discrimination, harassment, and victimisation, ensure fair treatment of all employees and applicants, and support and make reasonable adjustments for disabled employees. Responsibilities The Managing Director (currently Diane Elizabeth Gilby) is responsible for ensuring this policy is implemented, reviewed, and communicated to all staff. Managers and Supervisors are responsible for upholding the principles of equality in their teams and ensuring decisions are made fairly and transparently. Employees are expected to respect diversity, challenge discrimination, and report any concerns through the proper channels. Disabled Employees and Applicants ScientifEQ Ltd recognises the importance of supporting employees and applicants with disabilities. The company will ensure that disabled people are not treated less favourably because of their disability, make reasonable adjustments to working arrangements, the physical environment, or equipment to remove barriers to employment, provide equal opportunities for development and promotion, and treat any information regarding an employee’s disability as confidential. Where an employee becomes disabled during employment, ScientifEQ Ltd will make every reasonable effort to retain them in a suitable role and to provide appropriate support. Recruitment and Selection All recruitment processes are designed to ensure fairness and accessibility. Job descriptions and advertisements will be free from discriminatory language. Applicants will be assessed solely on their ability to meet the requirements of the role. Interview arrangements will be adapted, where necessary, to accommodate candidates with disabilities. Training and Development All staff involved in management, recruitment, or supervision will receive equality and diversity training. Employees will have equal access to training and development opportunities based on their performance and potential, not personal characteristics. Reporting Discrimination Any employee who believes they have been subjected to discrimination, harassment, or victimisation should raise the matter as soon as possible. Issues can be reported to a line manager, HR representative, or directly to the Managing Director. All complaints will be handled promptly, fairly, and confidentially. Disciplinary action may be taken against any employee found to have breached this policy. Monitoring and Review ScientifEQ Ltd will monitor equality and diversity performance through recruitment data and staff feedback, regular reviews of workplace accessibility and inclusivity, and an annual review of this policy to ensure ongoing compliance with the Equality Act 2010. 9. Breach of Policy Any breach of this policy will be treated as a disciplinary matter and may result in action up to and including dismissal. Approval This policy was approved by the Board of Directors on 30 September 2025 and is effective immediately.

Additional information

Business Review The company continued to build upon its strong foundations within the animal health diagnostics sector, maintaining a reputation for accuracy, reliability, and scientific integrity. During the year, ScientifEQ strengthened its position as a trusted laboratory partner for professionals seeking dependable, cost-effective testing solutions. Investments were made in laboratory infrastructure and process efficiency, ensuring timely results and continued compliance with quality control standards overseen by senior parasitology specialists. The business also expanded its collaboration with associated brands within the EPLA Group, supporting wider initiatives that promote responsible parasite management and evidence-based treatment decisions. The directors are satisfied with the company’s performance for the year and consider its financial position at the year end to be sound. Future Developments Looking ahead, ScientifEQ Ltd aims to continue expanding its professional testing services and developing new diagnostic methods to support the evolving needs of animal health professionals. Emphasis will remain on scientific excellence, sustainable laboratory practices, and strategic partnerships with universities, veterinary bodies, and affiliated organisations. The company also intends to further streamline its digital infrastructure to enhance client access to testing services and improve reporting systems.



Directors

The director shown below has held office during the whole of the period from
3 November 2023 to 31 December 2024

Diane Gilby

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
30 September 2025

And signed on behalf of the board by:
Name: Diane Gilby
Status: Director

SCIENTIFEQ LTD

Profit And Loss Account

for the Period Ended 31 December 2024

14 months to 31 December 2024


£
Turnover: 133,227
Cost of sales: ( 11,990 )
Gross profit(or loss): 121,237
Distribution costs: ( 21,046 )
Administrative expenses: ( 77,525 )
Other operating income: 0
Operating profit(or loss): 22,666
Interest receivable and similar income: 0
Interest payable and similar charges: 0
Profit(or loss) before tax: 22,666
Tax: 0
Profit(or loss) for the financial year: 22,666

SCIENTIFEQ LTD

Balance sheet

As at 31 December 2024

Notes 14 months to 31 December 2024


£
Called up share capital not paid: 0
Fixed assets
Intangible assets:   0
Tangible assets: 3 16,622
Total fixed assets: 16,622
Current assets
Stocks: 4 793
Debtors: 5 88,947
Cash at bank and in hand: 2,165
Investments:   0
Total current assets: 91,905
Prepayments and accrued income: 2,649
Creditors: amounts falling due within one year: 6 ( 88,509 )
Net current assets (liabilities): 6,045
Total assets less current liabilities: 22,667
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 22,667
Capital and reserves
Called up share capital: 1
Share premium account: 0
Other reserves: 0
Profit and loss account: 22,666
Total Shareholders' funds: 22,667

The notes form part of these financial statements

SCIENTIFEQ LTD

Balance sheet statements

For the year ending 31 December 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 30 September 2025
and signed on behalf of the board by:

Name: Diane Gilby
Status: Director

The notes form part of these financial statements

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    ScientifEQ Ltd Turnover Policy Approved by: Diane Elizabeth Gilby Date of approval: 30 September 2025 Next review date: 30 September 2026 Purpose The purpose of this policy is to define how ScientifEQ Ltd recognises turnover (revenue) in accordance with the principles of FRS 102 (Section 23 Revenue). This ensures that income from all laboratory, retail, and contract activities is recognised consistently and accurately, reflecting the timing and substance of the underlying transactions. Scope This policy applies to all sources of revenue generated by ScientifEQ Ltd, including retail orders for laboratory testing services, sale of test kits and related materials, and contract-based or account-managed laboratory services for professional clients. Policy Statement Turnover represents the fair value of consideration received or receivable for goods and services supplied in the ordinary course of business, excluding VAT and trade discounts. Revenue is recognised when the amount of revenue can be measured reliably, it is probable that economic benefits will flow to the company, and the performance obligations have been fulfilled in accordance with the terms of sale or service. Revenue Recognition by Activity Retail Orders (Laboratory Services and Test Kits) For retail orders received through the company’s online platform or direct sales channels, revenue is recognised at the point of payment, which coincides with the raising of the customer invoice and the dispatch of the test kit or associated materials. This approach reflects the point at which the company has transferred control of the goods or service to the customer and no further performance obligation remains. Contract Services and Account Clients For professional clients operating on a contract or account basis, revenue is recognised at the point the testing service is completed and the results are made available to the customer. Deferred Income Where payment is received in advance for services not yet performed (e.g., prepaid testing credits or unredeemed kits), the amount is recorded as Deferred Income within current liabilities and recognised as turnover once the service has been delivered or the kit dispatched. Credit Notes and Adjustments Any subsequent credit notes or adjustments ( for example, where a test is cancelled or duplicated) are recognised as reductions in turnover in the accounting period in which they arise. Review and Compliance This policy is reviewed annually to ensure continued compliance with The Companies Act 2006, FRS 102 Section 23 Revenue, and HMRC and Companies House reporting requirements. Approval This policy was approved by the Board of Directors on 30 September 2025 and is effective for all accounting periods beginning 1 January 2025. Diane Elizabeth Gilby Director, ScientifEQ Ltd

    Tangible fixed assets depreciation policy

    Tangible fixed assets are stated at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided to write off the cost, less the estimated residual value, of each asset on a straight-line basis over its estimated useful life as follows: Laboratory equipment – 4 to 5 years Computer and IT equipment – 3 years Office furniture and fittings – 5 years Residual values, useful lives, and depreciation methods are reviewed annually and adjusted if appropriate.

    Intangible fixed assets amortisation policy

    Intangible assets, such as proprietary testing methods or software systems, are capitalised when it is probable that they will generate future economic benefits. These assets are amortised over their estimated useful lives, typically 3 to 5 years.

    Valuation information and policy

    Stocks are valued at the lower of cost and net realisable value. Cost includes all direct costs of purchase and, where applicable, direct labour and overheads attributable to bringing the stock to its present condition. Work in progress represents uncompleted laboratory tests at the year-end and is valued at direct cost incurred to date.

    Other accounting policies

    The financial statements have been prepared in accordance with Financial Reporting Standard 102 (FRS 102), the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland, and the Companies Act 2006. The financial statements are prepared under the historical cost convention and are presented in pounds sterling (£), which is the company’s functional and presentational currency. 2. Going Concern The directors have assessed the company’s ability to continue as a going concern and are satisfied that the company has adequate resources to meet its obligations for at least twelve months from the date of approval of these financial statements. Accordingly, the financial statements have been prepared on a going concern basis. Debtors Trade and other debtors are recognised initially at transaction price and subsequently measured at amortised cost less provision for expected credit losses. Creditors Trade and other creditors are recognised initially at transaction price and subsequently measured at amortised cost. Cash and Cash Equivalents Cash and cash equivalents include cash at bank, cash in hand, and short-term deposits with maturities of three months or less. Taxation The tax charge for the year comprises current and deferred tax. Current tax is based on the taxable profit for the year using the tax rates enacted at the balance sheet date. Deferred tax is provided in full on temporary differences between the carrying amounts of assets and liabilities for financial reporting and tax purposes. Leases Operating lease payments are charged to the profit and loss account on a straight-line basis over the term of the lease. 12. Pensions The company operates a defined contribution pension scheme for eligible employees. Contributions are charged to the profit and loss account as they fall due. Financial Instruments The company only enters into basic financial instruments as defined under FRS 102. These include trade debtors, trade creditors, and cash. Judgements and Key Estimates Management reviews areas of significant judgement annually, including depreciation rates, impairment assessments, and recoverability of debtors, ensuring all estimates remain reasonable and consistent with business conditions.

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

  • 2. Employees

    14 months to 31 December 2024
    Average number of employees during the period 2

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
Additions 21,371 21,371
Disposals
Revaluations
Transfers
At 31 December 2024 21,371 21,371
Depreciation
Charge for year 4,749 4,749
On disposals
Other adjustments
At 31 December 2024 4,749 4,749
Net book value
At 31 December 2024 16,622 16,622

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

4. Stocks

14 months to 31 December 2024
£
Stocks 793
Total 793

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

5. Debtors

14 months to 31 December 2024
£
Trade debtors 88,947
Prepayments and accrued income 0
Total 88,947

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

6. Creditors: amounts falling due within one year note

14 months to 31 December 2024
£
Trade creditors 83,762
Taxation and social security 4,747
Total 88,509

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

7. Financial Commitments

At the balance sheet date, the company had no outstanding financial commitments under non-cancellable operating leases, finance leases, hire purchase contracts, or any other form of contractual obligation. The company also had no capital commitments authorised or contracted for at the balance sheet date. Accordingly, no provision or disclosure has been made in respect of any future capital expenditure, lease liabilities, or similar obligations. The directors confirm that, as at the reporting date, ScientifEQ Ltd’s financial commitments are limited to those disclosed within its trade creditors and accruals as stated in the balance sheet.

SCIENTIFEQ LTD

Notes to the Financial Statements

for the Period Ended 31 December 2024

8. Loans to directors

During the financial year, the company did not make, grant, or guarantee any loans, advances, or credit facilities to any director, nor to any person connected with a director, as defined under Section 413 of the Companies Act 2006. At the balance sheet date, no amounts were outstanding in respect of loans, advances, or guarantees made to or on behalf of the directors. Accordingly, no disclosures or provisions have been required in the financial statements in respect of directors’ loan transactions.